← Leaderboards
Zoltan N. Oltvai
Northwestern University
$3,786,753
Attributed
$3,786,753
Total exposure
6
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $850.1K · FY2005–10$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
Funding mix
By agency
NIH$3,786,753 · 6
By mechanism
U01$3,040,380 · 1
K02$473,059 · 1
R29$185,167 · 1
K08$86,107 · 1
P41$2,040 · 2
Top collaborators
No co-investigators on record.
Most similar at Northwestern University
Same institution · by research overlap
- Aaron I Packman$3,329,848
- Robert L. Murphy$48,634,037
- Babafemi O Taiwo$20,712,301
- Adilson E Motter$1,155,735
- Susan L Cohn$4,228,752
Others in their field
Top investigators on “Mutant”
- Kc Kent Lloyd · University Of California At Davis$103,993,616
- Constance Ann Benson · University Of California, San Diego$65,790,143
- Bruce A Beutler · Ut Southwestern Medical Center$34,438,453
- Oscar A. Carretero · Henry Ford Health System$33,594,856
- Stuart H Orkin · Children'S Hospital Boston$33,454,343
- Tracy T Batchelor · Dana-Farber Cancer Inst$31,851,614
Research focus
MutantModel Design /DevelopmentDietDrug DiscoveryComputer SimulationAntimicrobial EffectApplied ResearchBiological ProductsBacillus AnthracisDrug DesignAntibioticsBacterial GeneticsBaseBase SequenceBiochemical PathwayCell SurvivalBiotechnologyBioterrorismCategoriesCell BiologyBacteriaAntimicrobialAntimicrobial DrugComplex
Grant awards (16)
Integrated Antimicrobial Drug Discovery Scheme for Multidrug Resistant Bacteria$548,309
U01 · FY2010 · AI · contact PI
Integrated Antimicrobial Drug Discovery Scheme for Multidrug Resistant Bacteria$538,322
U01 · FY2009 · AI · contact PI
Integrated Antimicrobial Drug Discovery Scheme for Multidrug Resistant Bacteria$523,245
U01 · FY2008 · AI · contact PI
Integrated Antimicrobial Drug Discovery Scheme for Multidrug Resistant Bacteria$677,062
U01 · FY2007 · AI · contact PI
Integrated Antimicrobial Drug Discovery Scheme for Multidrug Resistant Bacteria$753,442
U01 · FY2006 · AI · contact PI
System-level properties of the E. coli metabolic network$95,621
K02 · FY2006 · AI · contact PI
ANTIBIOTIC TARGET IDENTIFICATION THROUGH METABOLIC NETWORK ANALYSIS$1,012
P41 · FY2006 · RR · contact PI
System-level properties of the E. coli metabolic network$95,621
K02 · FY2005 · AI
ANTIBIOTIC TARGET IDENTIFICATION THROUGH METABOLIC NETWORK ANALYSIS$1,028
P41 · FY2005 · RR
System-level properties of the E. coli metabolic network$56,042
K02 · FY2004 · AI
System-level properties of the E. coli metabolic network$34,533
K02 · FY2004 · AI
System-level properties of the E. coli metabolic network$95,621
K02 · FY2003 · AI
System-level properties of the E. coli metabolic network$95,621
K02 · FY2002 · AI
MECHANISM ®ULATION OF BCL-2 ANTIPROLIFERATIVE EFFECT$93,302
R29 · FY2001 · CA
MECHANISM ®ULATION OF BCL-2 ANTIPROLIFERATIVE EFFECT$91,865
R29 · FY2000 · CA
FUNCTION AND REGULATION OF PHOSPHORYLATED BC1-2$86,107
K08 · FY2000 · CA